
Archives: Resources
2026 ISG Provider Lens Report
Explore a comprehensive view of the industry’s digital service providers.
How AI Is Moving From Promise to Practice in Pharmacovigilance
AI is transitioning from theory to operational use in pharmacovigilance. Explore the opportunities, challenges, and emerging best practices driving the next phase of AI-enabled drug safety.
AI Transformation in Pharmacovigilance
Explore how AI transforms pharmacovigilance operations to improve efficiency, quality and compliance.
Precision medicine in cell and gene therapy
Learn how to navigate clinical, operational and regulatory complexities in cell and gene therapy to design adaptive, patient-centric precision medicine programs.
AI in Post-Approval Drug Safety: Effective Management of Real-World Patient Data
Explore how AI-driven pharmacovigilance improves post-market drug safety by enabling faster risk detection and optimizing compliance through scalable workflows.
How PPD™ Translate solutions ensure high-quality deliverables, on-time delivery and rapid turnaround
This white paper outlines how PPD Translate solutions deliver consistent, high-quality life sciences translations using an MSP model, AI tools, and expert quality checks.
Drug Development Lessons for 2026 Drawn from 2025 Realities
Learn key drug development trends for 2026 and how to apply 2025 insights to improve clinical trial strategy and outcomes.
Speeding drug development with integrated language solutions
Discover how embedding translation into every stage reduces handoffs, improves quality, and speeds drug development.
Smarter evidence, faster decisions: How AI is transforming clinical development and commercialization
Learn how AI-driven real-world data analytics improve clinical decisions, optimize datasets, and enhance evidence generation.